National Academies Press: OpenBook
« Previous: 4 Conclusions
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2021. Progress of Four Programs from the Comprehensive Addiction and Recovery Act. Washington, DC: The National Academies Press. doi: 10.17226/26060.
×

References

Ahmad, F. B., L. M. Rossen, and P. Sutton. 2020. Provisional drug overdose death counts (NCHS Vital Statistics Rapid Release). https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#citation (accessed January 18, 2021).

Andrilla, C. H. A., T. E. Moore, D. G. Patterson, and E. H. Larson. 2019. Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: A 5-year update. Journal of Rural Health 35(1):108–112. doi: 10.1111/jrh.12307.

Ashford, R. D., B. Curtis, and A. M. Brown. 2018. Peer-delivered harm reduction and recovery support services: Initial evaluation from a hybrid recovery community drop-in center and syringe exchange program. Harm Reduction Journal 15(1):52. doi: 10.1186/s12954-018-0258-2.

Bach, P., and D. Hartung. 2019. Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders. Addiction Science & Clinical Practice 14(1):30. doi: 10.1186/s13722-019-0158-0.

Becan, J. E., J. P. Bartkowski, D. K. Knight, T. R. A. Wiley, R. DiClemente, L. Ducharme, W. N. Welsh, D. Bowser, K. McCollister, M. Hiller, A. C. Spaulding, P. M. Flynn, A. Swartzendruber, M. F. Dickson, J. H. Fisher, and G. A. Aarons. 2018. A model for rigorously applying the Exploration, Preparation, Implementation, Sustainment (EPIS) framework in the design and measurement of a large scale collaborative multi-site study. Health & Justice 6(1):9. doi: 10.1186/s40352-018-0068-3.

Bray, J. W., F. K. Del Boca, B. G. McRee, S. W. Hayashi, and T. F. Babor. 2017. Screening, Brief Intervention and Referral to Treatment (SBIRT): Rationale, program overview and cross-site evaluation. Addiction 112(Suppl 2):3–11.

Brown, M., M. Rowe, A. Cunningham, and A. N. Ponce. 2018. Evaluation of a comprehensive SAMHSA service program for individuals experiencing chronic homelessness. The Journal of Behavioral Health Services & Research 45(4):605–613. doi: 10.1007/s11414-018-9589-8.

CDC (Centers for Disease Control and Prevention). 2018. New data show growing complexity of drug overdose deaths in America. https://www.cdc.gov/media/releases/2018/p1221-complexity-drug-overdose.html (accessed January 12, 2021).

CDC. 2019. Other drugs. https://www.cdc.gov/drugoverdose/data/otherdrugs.html (accessed March 2, 2020).

CDC. 2020a. Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID19 pandemic (Health Alert Network). https://emergency.cdc.gov/han/2020/han00438.asp (accessed February 1, 2021).

CDC. 2020b. Synthetic opioid overdose data. https://www.cdc.gov/drugoverdose/data/fentanyl.html (accessed March 2, 2020).

Czeisler, M. É., R. I. Lane, E. Petrosky, J. F. Wiley, A. Christensen, R. Njai, M. D. Weaver, R. Robbin, E. R. Facer-Childs, L. K. Barger, C. A. Czeisler, M. E. Howard, and S. M. W. Rajaratnam. 2020. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic—United States, June 24–30, 2020. Morbidity and Mortality Weekly Report 69(32):1049–1057. https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a1.htm (accessed January 12, 2021).

Dasgupta, N., L. Beletsky, and D. Ciccarone. 2018. Opioid crisis: No easy fix to its social and economic determinants. American Journal of Public Health 108(2):182–186. doi: 10.2105/AJPH.2017.304187.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2021. Progress of Four Programs from the Comprehensive Addiction and Recovery Act. Washington, DC: The National Academies Press. doi: 10.17226/26060.
×

Davis, C. S., S. Ruiz, P. Glynn, G. Picariello, and A. Y. Walley. 2014. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. American Journal of Public Health 104(8):e7–e9. doi: 10.2105/AJPH.2014.302062.

Englander, H., J. Gregg, J. Gullickson, O. Cochran-Dumas, C. Colasurdo, J. Alla, D. Collins, and C. Nicolaidis. 2020. Recommendations for integrating peer mentors in hospital-based addiction care. Substance Abuse 41(4):419–424. doi: 10.1080/08897077.2019.1635968.

GAO (Government Accountability Office). 2018. Medicaid demonstrations: Evaluations yielded limited results, underscoring need for changes to federal policies and procedures, GAO-18-220. Washington, DC: GAO.

Glasgow, R. E., H. G. McKay, J. D. Piette, and K. D. Reynolds. 2001. The RE-AIM framework for evaluating interventions: What can it tell us about approaches to chronic illness management? Patient Education and Counseling 44(2):119–127. doi: 10.1016/s0738-3991(00)00186-5.

Gostin, L. O., J. G. Hodge, Jr., and S. A. Noe. 2017. Reframing the opioid epidemic as a national emergency. Journal of the American Medical Association 318(16):1539–1540. doi: 10.1001/jama.2017.13358.

Guy, G. P., Jr., T. M. Haegerich, M. E. Evans, J. L. Losby, R. Young, and C. M. Jones. 2019. Vital Signs: Pharmacy-based naloxone dispensing—United States, 2012–2018. Morbidity and Mortality Weekly Report 68(31):679–686. https://www.cdc.gov/mmwr/volumes/68/wr/pdfs/mm6831e1-H.pdf (accessed January 12, 2021).

HHS (Department of Health and Human Services). 2021 (January 7). Renewal of determination that a public health emergency exists. https://www.phe.gov/emergency/news/healthactions/phe/Pages/opioids-7Jan2021.aspx (accessed February 8, 2021).

HHS OIG (Office of Inspector General). 2020. Geographic disparities affect access to buprenorphine services for opioid use disorder. https://oig.hhs.gov/oei/reports/oei-12-17-00240.asp (accessed February 12, 2021).

Jacob, R. T., R. D. Goddard, and E. S. Kim. 2014. Assessing the use of aggregate data in the evaluation of school-based interventions: Implications for evaluation research and state policy regarding public-use data. Educational Evaluation and Policy Analysis 36(1):44–66. doi: 10.3102/0162373713485814.

Krieger, M. S., W. C. Goedel, J. A. Buxton, M. Lysyshyn, E. Bernstein, S. G. Sherman, J. D. Rich, S. E. Hadland, T. C. Green, and B. D. Marshall. 2018a. Use of rapid fentanyl test strips among young adults who use drugs. International Journal of Drug Policy 61:52–58. doi: 10.1016/j.drugpo.2018.09.009.

Krieger, M. S., J. L. Yedinak, J. A. Buxton, M. Lysyshyn, E. Bernstein, J. D. Rich, T. C. Green, S. E. Hadland, and B. D. Marshall. 2018b. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduction Journal 15(1):7. doi: 10.1186/s12954-018-0213-2.

Lago, L. 2013. Statistical methods for analysis of aggregate health performance data. Presented to the COAG Reform Council at the Centre for Health Service Development, Australia Health Service Research Institute, Wollongong, Australia. https://ro.uow.edu.au/cgi/viewcontent.cgi?referer=https://www.google.com/&httpsredir=1&article=1261&context=ahsri (accessed February 12, 2021).

McHugo, G. J., N. Kammerer, E. W. Jackson, L. S. Markoff, M. Gatz, M. J. Larson, R. Mazelis, and K. Hennigan. 2005. Women, Co-occurring Disorders, and Violence Study: Evaluation design and study population. Journal of Substance Abuse Treatment 28(2):91–107. doi: 10.1016/j.jsat.2004.08.009.

NASEM (National Academies of Sciences, Engineering, and Medicine). 2017. Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use. Washington, DC: The National Academies Press. https://doi.org/10.17226/24781.

NASEM. 2019. Medications for opioid use disorder save lives. Washington, DC: The National Academies Press. https://doi.org/10.17226/25310.

NASEM. 2020a. Opportunities to improve opioid use disorder and infectious disease services: Integrating responses to a dual epidemic. Washington, DC: The National Academies Press. https://doi.org/10.17226/25626.

NASEM. 2020b. Measuring success in substance use grant programs: Outcomes and metrics for improvement. Washington, DC: The National Academies Press. https://doi.org/10.17226/25745.

Naumann, R. B., C. P. Durrance, S. I. Ranapurwala, A. E. Austin, S. Proescholdbell, R. Childs, S. W. Marshall, S. Kansagra, and M. E. Shanahan. 2019. Impact of a community-based naloxone distribution program on opioid overdose death rates. Drug and Alcohol Dependence 204:107536. doi: 10.1016/j.drugalcdep.2019.06.038.

NIDA (National Institute on Drug Abuse). 2020. Overdose death rates. https://www.drugabuse.gov/related-topics/trendsstatistics/overdose-death-rates (accessed December 28, 2020).

Oquendo, M. A., and N. D. Volkow. 2018. Suicide: A silent contributor to opioid-overdose deaths. The New England Journal of Medicine 378(17):1567–1569. doi: 10.1056/NEJMp1801417.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2021. Progress of Four Programs from the Comprehensive Addiction and Recovery Act. Washington, DC: The National Academies Press. doi: 10.17226/26060.
×

Peiper, N. C., S. D. Clarke, L. B. Vincent, D. Ciccarone, A. H. Kral, and J. E. Zibbell. 2019. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the southeastern United States. International Journal of Drug Policy 63:122–128. https://doi.org/10.1016/j.drugpo.2018.08.007.

Ryan, S. A., and C. B. Thompson. 2002. The use of aggregate data for measuring practice improvement. Seminars for Nurse Managers 10(2):90–94.

Saloner, B., and J. C. Maclean. 2020. Specialty substance use disorder treatment admissions steadily increased in the four years after Medicaid expansion. Health Affairs 39(3):453–461. doi: 10.1377/hlthaff.2019.01428.

SAMHSA (Substance Abuse and Mental Health Services Administration). 2013. Government Performance and Results Act (GPRA) client outcome measures for discretionary programs: Question-by-question instruction guide. https://www.samhsa.gov/sites/default/files/GPRA/SAIS_GPRA_Services_Tool_QxQ_final.pdf (accessed February 23, 2021).

SAMHSA. 2016. Facing addiction in America: The Surgeon General’s report on alcohol, drugs, and health. https://addiction.surgeongeneral.gov/sites/default/files/surgeon-generals-report.pdf (accessed December 30, 2020).

SAMHSA. 2017a. Comprehensive Addiction and Recovery Act: Building communities of recovery: (Initial announcement) Funding Opportunity Announcement TI-17-015. https://www.samhsa.gov/grants/grant-announcements/ti-19-003 (accessed March 13, 2020).

SAMHSA. 2017b. Comprehensive Addiction and Recovery Act: State pilot grant program for treatment for pregnant and postpartum women: (Initial Announcement) Funding Opportunity Announcement TI-17-016. https://www.samhsa.gov/grants/grant-announcements/ti-20-010 (accessed March 13, 2020).

SAMHSA. 2017c. First responders—Comprehensive Addiction and Recovery Act: (Initial Announcement) Funding Opportunity Announcement SP-17-005. https://www.samhsa.gov/grants/grant-announcements/ti-19-004 (accessed March 3, 2020).

SAMHSA. 2017d. Improving access to overdose treatment: (Initial Announcement) Funding Opportunity Announcement SP-17-006. https://www.samhsa.gov/grants/grant-announcements/sp-18-006 (accessed March 13, 2020).

SAMHSA. 2017e. SP-17-005 individual grant awards 2017. https://www.samhsa.gov/grants/awards/2017/SP-17-005 (accessed December 30, 2020).

SAMHSA. 2017f. SP-17-006 individual grant awards 2017. https://www.samhsa.gov/grants/awards/2017/SP-17-006 (accessed December 30, 2020).

SAMHSA. 2017g. TI-17-015 individual grant awards 2017. https://www.samhsa.gov/grants/awards/2017/TI-17-015 (accessed December 30, 2020).

SAMHSA. 2017h. TI-17-016 individual grant awards 2017. https://www.samhsa.gov/grants/awards/2017/TI-17-016 (accessed December 30, 2020).

SAMHSA. 2018a. Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. https://store.samhsa.gov/sites/default/files/d7/priv/sma18-5054.pdf (accessed January 12, 2021).

SAMHSA, 2018b. Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). Rockville, MD: Center for Behavioral Health Statistics and Quality, SAMHSA.

SAMHSA, 2018c. Minority AIDS Initiative (MAI) cross-site evaluation: Final report. Rockville, MD: SAMHSA.

SAMHSA. 2018d. SP-17-005 individual grant awards 2018. https://www.samhsa.gov/grants/awards/2018/SP-17-005 (accessed December 30 2020).

SAMHSA. 2018e. SP-18-006 individual grant awards 2018. https://www.samhsa.gov/grants/awards/2018/SP-18-006 (accessed December 30, 2020).

SAMHSA. 2018f. TI-17-015 individual grant awards 2018. https://www.samhsa.gov/grants/awards/2018/TI-17-015 (accessed December 30, 2020).

SAMHSA. 2018g. TI-17-016 individual grant awards 2018. https://www.samhsa.gov/grants/awards/2018/TI-17-016 (accessed December 30, 2020).

SAMHSA. 2019a. A guide to SAMHSA’s strategic prevention framework. Rockville, MD: SAMHSA.

SAMHSA. 2019b. TI-19-003 individual grant awards 2019. https://www.samhsa.gov/grants/awards/2019/TI-19-003 (accessed February 12, 2021).

SAMHSA. 2020a. Building Communities of Recovery: (Modified Announcement) Funding Opportunity Announcement TI-21-004. https://www.samhsa.gov/grants/grant-announcements/TI-21-004 (accessed February 12, 2021).

SAMHSA. 2020b. State Pilot Grant Program for Treatment for Pregnant and Postpartum Women: (Modified Announcement) Funding Opportunity Announcement TI-21-002. https://www.samhsa.gov/grants/grant-announcements/ti-21-002 (accessed February 12, 2021).

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2021. Progress of Four Programs from the Comprehensive Addiction and Recovery Act. Washington, DC: The National Academies Press. doi: 10.17226/26060.
×

Scharf, D. M., N. K. Eberhart, N. S. Hackbarth, M. Horvitz-Lennon, R. Beckman, B. Han, S. L. Lovejoy, H. A. Pincus, and M. A. Burnam. 2014. Evaluation of the SAMHSA Primary and Behavioral Health Care Integration (PBHCI) grant program: Final report. RAND Health Quarterly 4(3):6.

Schumann, H., T. Erickson, T. M. Thompson, J. L. Zautcke, and J. S. Denton. 2008. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clinical Toxicology (Philadelphia, PA.) 46(6):501–506. doi: 10.1080/15563650701877374.

Seth, P., L. Scholl, R. A. Rudd, and S. Bacon. 2018. Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. Morbidity and Mortality Weekly Report 67(12):349–358. https://www.cdc.gov/mmwr/volumes/67/wr/mm6712a1.htm (accessed January 12, 2021).

Slavova, S., P. Rock, H. M. Bush, D. Quesinberry, and S. L. Walsh. 2020. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug and Alcohol Dependence 214:108176. doi: 10.1016/j. drugalcdep.2020.108176.

Somerville, N. J., J. O’Donnell, R. M. Gladden, J. E. Zibbell, T. C. Green, M. Younkin, S. Ruiz, H. Babakhanlou-Chase, M. Chan, B. P. Callis, J. Kuramoto-Crawford, H. M. Nields, and A. Y. Walley. 2017. Characteristics of fentanyl overdose—Massachusetts, 2014–2016. Morbidity and Mortality Weekly Report 66(14):382–386. doi: 10.15585/mmwr.mm6614a2.

Stack, E., G. Leichtling, J. E. Larsen, M. Gray, J. Pope, J. M. Leahy, L. Gelberg, A. Seaman, and P. T. Korthuis. 2020. The impacts of COVID-19 on mental health, substance use, and overdose concerns of people who use drugs in rural communities. Journal of Addiction Medicine, online ahead of print. doi: 10.1097/ADM.0000000000000770.

Steadman, H. J., M. W. Deane, J. P. Morrissey, M. L. Westcott, S. Salasin, and S. Shapiro. 1999. A SAMHSA research initiative assessing the effectiveness of jail diversion programs for mentally ill persons. Psychiatric Services 50(12):1620–1623. doi: 10.1176/ps.50.12.1620.

Torralva, R., and A. Janowsky. 2019. Noradrenergic mechanisms in fentanyl-mediated rapid death explain failure of naloxone in the opioid crisis. Journal of Pharmacology and Experimental Therapeutics 371(2):453–475. doi: 10.1124/jpet.119.258566.

Volkow, N. D., and C. Blanco. 2020. The changing opioid crisis: Development, challenges and opportunities. Molecular Psychiatry, online ahead of print. doi: 10.1038/s41380-020-0661-4.

Wakeman, S. E., Y. Chang, S. Regan, L. Yu, J. Flood, J. Metlay, and N. Rigotti. 2019. Impact of fentanyl use on buprenorphine treatment retention and opioid abstinence. Journal of Addiction Medicine 13(4):253–257. doi: 10.1097/ADM.0000000000000486.

Williams, A. R., E. V. Nunes, A. Bisaga, F. R. Levin, and M. Olfson. 2019. Development of a Cascade of Care for responding to the opioid epidemic. American Journal of Drug and Alcohol Abuse 45(1):1–10. doi: 10.1080/00952990.2018.1546862.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2021. Progress of Four Programs from the Comprehensive Addiction and Recovery Act. Washington, DC: The National Academies Press. doi: 10.17226/26060.
×
Page 79
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2021. Progress of Four Programs from the Comprehensive Addiction and Recovery Act. Washington, DC: The National Academies Press. doi: 10.17226/26060.
×
Page 80
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2021. Progress of Four Programs from the Comprehensive Addiction and Recovery Act. Washington, DC: The National Academies Press. doi: 10.17226/26060.
×
Page 81
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2021. Progress of Four Programs from the Comprehensive Addiction and Recovery Act. Washington, DC: The National Academies Press. doi: 10.17226/26060.
×
Page 82
Next: Appendix A: Supplementary Program Information »
Progress of Four Programs from the Comprehensive Addiction and Recovery Act Get This Book
×
Buy Paperback | $60.00 Buy Ebook | $48.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Substance use disorder (SUD) and opioid use disorder are significant public health threats that affect millions of Americans each year. To help address overdose deaths and lack of access to treatment, the Comprehensive Addiction and Recovery Act (CARA) was signed into law on July 22, 2016. CARA is extensive legislation intended to address many facets of the opioid epidemic, including prevention, treatment, recovery, law enforcement, criminal justice reform, and overdose reversal. It authorizes more than $181 million each year in new funding to fight the opioid epidemic and it requires the implementation of programs and services across the United States to address SUD and recovery.

Following the passage of CARA, the Departments of Education, Health and Human Services (HHS), and Labor, along with the 2018 Related Agencies Appropriations Act, included appropriations for a study of the Substance Abuse and Mental Health Services Administration (SAMHSA) components in CARA, to be conducted by the National Academies of Sciences, Engineering, and Medicine. In response to this charge, the National Academies formed an ad hoc committee to review outcomes achieved by four programs funded by SAMHSA through CARA: State Pilot Grant Program for Treatment for Pregnant and Postpartum Women (PPW-PLT), Building Communities of Recovery (BCOR), Improving Access to Overdose Treatment (OD Treatment Access), and First Responders (FR-CARA). The committee's review is designed to result in three reports over 5 years. This report, the second in the series, reviews reported outcomes and metrics to assess progress toward achieving program goals.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!